Why the study?
Does orciprenaline inhibit recurrent ventricular fibrillation in a patient with Brugada syndrome experiencing an electrical storm?
Does orciprenaline inhibit recurrent ventricular fibrillation in a patient with Brugada syndrome experiencing an electrical storm?
Intravenous orciprenaline may be an effective acute treatment for inhibiting recurrent ventricular fibrillation (electrical storm) in patients with Brugada syndrome.
May support orciprenaline for acute Brugada electrical storm; leaves open confirmation in prospective trials.
We report a case of an electrical storm occurring in a patient implanted with a cardioverter defibrillator for symptomatic Brugada syndrome. Recurrent ventricular fibrillation was initiated by short-coupled premature ventricular beats of right ventricular origin, associated with a fixed Brugada type 2 electrocardiographic pattern. Low-dose orciprenaline application as an intravenous bolus followed by an infusion inhibited the recurrence of ventricular fibrillation and normalized the electrocardiographic pattern. Low-dose oral quinidine had only a moderate effect on the ST-elevation.
No takes yet. Share an insight, caveat, or question.
Kyriazis et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: